Some obvious questions arise from this:
1. Was Kingdon aware he was soon to depart when overseeing the recent layoffs?
2. Was Kingdon even really in the loop when the restructuring was undertaken?
3. How does one claim things will improve when the now interim CEO stepped down to allow Mark Kingdon to bring a more commercial focus to the organisation? No-one is claiming such improvement at this stage, but it’s a fair assumption that the aim is for things to go up. Unless it’s part of a scale-down for buyout of course.
All that said – the change could be a good thing. At the very least it’s a temporary thing until the Lab or other future controlling influence determines what the next step is. What remains certain is uncertainty – which can’t help Linden Lab in the short-term but with luck it will assist in the all-important longer term.